WellBeam Secures $10M Series A Funding Led by Wittington Ventures

Why It Matters

The infusion of $10 million positions WellBeam to deepen data exchange across the fragmented U.S. healthcare ecosystem, a critical step toward improving care continuity and reducing costs, and signals strong investor confidence in interoperability solutions.

Deal Summary

Redwood City‑based health‑tech firm WellBeam announced the close of a $10 million Series A round. The round was led by Wittington Ventures with participation from F‑Prime, Advocate Health and Oncology Ventures, and will fund expansion of its interoperability platform across health systems.